Biotech IPOs dying on the vine (Reuters)
Posted by admin on November 3, 2008 under News | 
Be the First to Comment
Biotech IPOs dying on the vine (Reuters)
Reuters – While the market for initial public offerings has shut down in all industries, with no deals in the United States in nearly three months, biotechnology companies desperate for capital will likely be waiting in line far longer than others when it does re-open.
Add A Comment